Skip to main navigation Skip to search Skip to main content

The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer

Alisha Bent, Shreya Raghavan, Arvind Dasari, Scott Kopetz

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science